The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Lbp Am Sa

LBP AM SA increased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 49,913 shares of the medical device company's stock after acquiring an additional 3,116 shares during the period. LBP AM SA's holdings in Cooper Companies were worth $4,589,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in COO. Ashton Thomas Securities LLC purchased a new position in Cooper Companies in the 3rd quarter worth approximately $25,000. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies in the 4th quarter worth $33,000. OFI Invest Asset Management purchased a new stake in shares of Cooper Companies in the 4th quarter worth $34,000. Covestor Ltd increased its stake in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Finally, Brown Brothers Harriman & Co. increased its stake in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after purchasing an additional 275 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

COO has been the subject of several analyst reports. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Wells Fargo & Company upped their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and an average target price of $111.89.

Remove Ads

Cooper Companies Trading Up 0.2 %

NASDAQ COO traded up $0.13 during trading on Tuesday, hitting $80.04. The stock had a trading volume of 1,719,988 shares, compared to its average volume of 1,265,079. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.01 billion, a price-to-earnings ratio of 41.05, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The stock has a 50 day simple moving average of $90.68 and a 200 day simple moving average of $98.56.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.